IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q1 2020 Holdings

Filed 2020-05-15 | 14 holdings | $12.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$12.6M436,51498.1%
Spdr SER TR(XBI)PutS&P BIOTECH78464A870$77.4K1,000,0000.6%
Uniqure NV(QURE)SHSN90064101$23.8K501,9750.2%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$22.7K1,237,3790.2%
Anaptysbio Inc(ANAB)COM032724106$20.3K1,439,0790.2%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$17.0K1,499,9700.1%
Spero Therapeutics Inc(SPRO)COM84833T103$14.7K1,818,1400.1%
Proqr Thrapeutics N VSHS EURON71542109$13.2K2,401,5700.1%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$12.9K1,047,1840.1%
Pieris Pharmaceuticals IncCOM720795103$12.7K5,575,5300.1%
Merus N VCOMN5749R100$9.3K770,1830.1%
Regenxbio Inc(RGNX)COM75901B107$8.8K273,2110.1%
Galapagos NV(GLPG)SPON ADR36315X101$8.7K44,2340.1%
Morphosys AGSPONSORED ADS617760202$2.4K95,8980.0%